Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 11/20 | 0.64 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | CCNC | P24863 | 1/20 | 0.43 |
| ▸ | CDK8 | P49336 | 1/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18725379 | 0.89 | CHRM1 (0.65) | CHRM1 | |
| SCHEMBL6891034 | 0.87 | CHRM1 (0.65) | CHRM1CCNCCDK8AURKAAURKB | |
| SCHEMBL19932634 | 0.86 | CHRM1 (0.85) | CHRM1 | |
| SCHEMBL21936383 | 0.85 | CHRM1 (0.61) | CHRM1AURKAAURKB | |
| SCHEMBL21935673 | 0.84 | CHRM1 (0.62) | CHRM1 | |
| SCHEMBL18756570 | 0.83 | CHRM1 (0.46) | CHRM1 | |
| SCHEMBL18756664 | 0.82 | CHRM1 (0.46) | CHRM1 | |
| SCHEMBL18756376 | 0.81 | CHRM1 (0.47) | CHRM1 | |
| SCHEMBL30671882 | 0.80 | CHRM1 (0.69) | CHRM1 | |
| SCHEMBL26966585 | 0.80 | CHRM1 (0.69) | CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3156397-B1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2019-08-07 | — | — | EP | disclosed |
| EP-3156397-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2017-04-19 | — | — | EP | disclosed |